AMA to lead independent review of flu, COVID and RSV vaccines after federal pullback
Lead: The American Medical Association (AMA) announced on 11 February 2026 that it will lead a monthly, independent review of the safety and effectiveness of influenza, Covid-19 and respiratory syncytial virus (RSV) vaccines for the coming fall. The move follows a series of policy shifts at the Department of Health and Human Services (HHS) under … Read more